K Number
K980927
Device Name
LACTOSORB PANELS AND FASTENERS
Manufacturer
Date Cleared
1998-06-05

(86 days)

Product Code
Regulation Number
872.4760
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The LactoSorb® Panels and Fasteners are used to maintain the position of bony fragments in mandibular bone graft procedures and are used in conjunction with rigid internal fixation.
Device Description
The LactoSorb® devices are made of bioresorbable and biocompatible polymers that have been used in surgical procedures for years. LactoSorb® resorbable copolymer is a synthetic polyester derived from lactic and glycolic acids. Polylactic/polyglycolic acid copolymer degrades and resorbs IN VIVO by hydrolysis to lactic and glycolic acids which are then metabolized by the body. The LactoSorb® material has been found to be biocompatible in both soft tissue and bone tissue. Both preclinical and clinical studies have proven the safety and effectiveness of these devices, in trauma and reconstructive procedures in the midface and craniofacial skeleton .
More Information

Not Found

No
The summary describes a bioresorbable implant made of polymers, with no mention of software, algorithms, or any technology related to AI or ML.

No
The device is used to maintain the position of bony fragments, which is a supportive mechanical function, not a therapeutic one in the sense of treating a disease or disorder directly through chemical or biological means. Its purpose is to aid in the healing process by providing stability.

No

Explanation: The device, LactoSorb® Panels and Fasteners, is described as being used to maintain the position of bony fragments in mandibular bone graft procedures and in conjunction with rigid internal fixation. This indicates it is a surgical implant for treatment, not a device used to identify or determine the nature of a disease or condition.

No

The device description clearly states it is made of bioresorbable and biocompatible polymers, indicating it is a physical implant, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to "maintain the position of bony fragments in mandibular bone graft procedures and are used in conjunction with rigid internal fixation." This describes a surgical implant used directly on the patient's bone.
  • Device Description: The description details the material composition (bioresorbable polymers) and how it functions in vivo (degrades and resorbs within the body).
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.

IVD devices are used outside the body to analyze samples, while this device is implanted within the body for structural support.

N/A

Intended Use / Indications for Use

The LactoSorb® Panels and Fasteners are used to maintain the position of bony fragments in mandibular bone graft procedures and are used in conjunction with rigid internal fixation.

Product codes

JEY

Device Description

The LactoSorb® Panels and Fasteners are used to maintain the position of bony fragments in mandibular bone graft procedures and are used in conjunction with rigid internal fixation.

The LactoSorb® devices are made of bioresorbable and biocompatible polymers that have been used in surgical procedures for years. LactoSorb® resorbable copolymer is a synthetic polyester derived from lactic and glycolic acids. Polylactic/polyglycolic acid copolymer degrades and resorbs IN VIVO by hydrolysis to lactic and glycolic acids which are then metabolized by the body. The LactoSorb® material has been found to be biocompatible in both soft tissue and bone tissue. Both preclinical and clinical studies have proven the safety and effectiveness of these devices, in trauma and reconstructive procedures in the midface and craniofacial skeleton.

Use of the LactoSorb® devices in this non-load bearing mandibular bone graft indication does not raise any new safety and effectiveness questions.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

mandibular bone

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K980927

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.4760 Bone plate.

(a)
Identification. A bone plate is a metal device intended to stabilize fractured bone structures in the oral cavity. The bone segments are attached to the plate with screws to prevent movement of the segments.(b)
Classification. Class II.

0

510 (k) Summary of Safety and Effectiveness

down and with the time of the two has " Internet and their has the

q8092j

Submitter : Biomet, Inc. P.O. Box 587 Airport Industrial Park 46581-0587 Warsaw, IN

Mary L. Verstynen Contact Person:

Product Code: JEY

LactoSorb® Panels and Fasteners Device Name:

The LactoSorb® Panels and Fasteners are used to maintain the position of bony fragments in mandibular bone graft procedures and are used in conjunction with rigid internal fixation.

The LactoSorb® devices are made of bioresorbable and biocompatible polymers that have been used in surgical procedures for years. LactoSorb® resorbable copolymer is a synthetic polyester derived from lactic and glycolic acids. Polylactic/polyglycolic acid copolymer degrades and resorbs IN VIVO by hydrolysis to lactic and glycolic acids which are then metabolized by the body. The LactoSorb® material has been found to be biocompatible in both soft tissue and bone tissue. Both preclinical and clinical studies have proven the safety and effectiveness of these devices, in trauma and reconstructive procedures in the midface and craniofacial skeleton .

Use of the LactoSorb® devices in this non-load bearing mandibular bone graft indication does not raise any new safety and effectiveness questions.

ﻟﻠﻘﺎﻧﻮﻥ ﺍﻟﻤﺪﻳﻨﺔ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤ

Image /page/0/Picture/11 description: The image shows the number 00004 in a bold, sans-serif font. The numbers are black against a white background. The numbers are evenly spaced and aligned horizontally.

1

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the logo is an abstract symbol that resembles an eagle or bird in flight, composed of several curved lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

5 1898 JUN

Ms. Mary Verstynen Clinical Research Manager Biomet, Incorporated Airport Industrial Park P.O. Box 587 46581-0587 Warsaw, Indiana

Re : K980927 Lactosorb Panels and Fasteners Trade Name: Regulatory Class: II Product Code: JEY Dated: March 9, 1998 Received: March 11, 1998

Dear Ms. Verstynen:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ರ್ಕ substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531

2

Page 2 - Ms. Verstynen

through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.

This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address

"http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Timothy A. Ulatowski

Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Page _ 1 of 1

510(k) NUMBER (IF KNOWN):

DEVICE NAME: LactoSorb Panels and Fasteners

INDICATIONS FOR USE:

The LactoSorb Panels and Fasteners are used to maintain the position of bony fragments in mandibular bone graft procedures and are used in conjunction with rigid internal fixation.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| Prescription Use
(Per 21 CFR 801.109) | ✓ | OR | Over-The-Counter-Use
(Optional Format 1-2-96) |

---------------------------------------------------------------------------------------------------------------------------------------

Susan Roaser
(Division Sign-Off)
Division of Dental, Infection Control,
and General Hospital Devices

510(k) Number10980927
-------------------------

00003

11 - 1 - 1 - 1 - 1 - 1 - 1